MARKET

RCKT

RCKT

ROCKET PHARMACEU
NASDAQ

Real-time Quotes | Nasdaq Last Sale

20.76
-0.69
-3.22%
After Hours: 20.78 +0.02 +0.10% 16:00 01/17 EST
OPEN
21.63
PREV CLOSE
21.45
HIGH
21.74
LOW
20.58
VOLUME
367.98K
TURNOVER
--
52 WEEK HIGH
27.59
52 WEEK LOW
10.76
MARKET CAP
1.14B
P/E (TTM)
-11.2338
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of RCKT and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 9 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

RCKT News

  • What You Must Know About Rocket Pharmaceuticals, Inc.'s (NASDAQ:RCKT) Beta Value
  • Simply Wall St..01/09 14:44
  • Here's Why Rocket Pharmaceuticals (RCKT) is a Great Momentum Stock to Buy
  • Zacks.01/06 17:00
  • Rocket Pharmaceuticals Announces Participation at the 38th Annual J.P. Morgan Healthcare Conference
  • Business Wire.01/06 12:00
  • Corporate Insiders Pull the Trigger on 3 Buy-Rated Stocks
  • TipRanks.12/29/2019 08:24

More

Industry

Biotechnology & Medical Research
-0.16%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About RCKT

Rocket Pharmaceuticals, Inc. is a clinical-stage biotechnology company. The Company is focused on developing gene therapy treatment options for rare, devastating diseases. The Company’s multi-platform development approach applies the well-established lentiviral vector (LVV) and adeno-associated viral vector (AAV) gene therapy platforms. The Company’s lead clinical program is a LVV-based gene therapy for the treatment of Fanconi Anemia (FA), a genetic disease that leads to bone marrow failure and potentially cancer. Its additional pipeline programs for bone marrow-derived disorders are for Pyruvate Kinase Deficiency (PKD), Leukocyte Adhesion Deficiency-I (LAD-I) and Infantile Malignant Osteopetrosis (IMO). The Company is also developing an AAV-based gene therapy program for pediatric heart failure indication, Danon disease.
More

Webull offers Rocket Pharmaceuticals Inc (RCKT) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.